AzTrials
AzTrials

Intubation, IntratrachealNCT03368599

Endobronchial Intubation of Double-lumen Tube: Conventional Method vs Fiberoptic Bronchoscope Guide Method

A study testing Bronchoscope guided advancement and Conventional advancement in people with Intubation, Intratracheal and Postoperative Complications, run by Seoul National University Bundang Hospital at 1 site in South Korea.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Double lumen tube (DLT) needs to be intubated to isolate ventilations of left and right lungs for thoracic surgery. Post-operative sore throat and hoarseness are more frequent with DLT intubation than with single one. Read more about this study

Who is it for?
Ages 20 to 75 years
What is being tested?
Bronchoscope guided advancement and Conventional advancement
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
136 participants
Where
1 siteSouth Korea
Study dates
15 Jan 2018to 31 Jan 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 75 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • ASA (American Society of Anesthesiologists) class I - III
  • Elective thoracic surgery
  • Left-sided DLT intubation for one-lung ventilation

Who cannot join

  • Female, height < 160 cm
  • Pre-existing sore throat, hoarseness or airway injury
  • Duration of surgery > 6 h
  • Upper respiratory tract infection
  • Cervical spine diseases
  • Presence of tracheostomy
Show all 15Show fewer
  • Pharyngeal neoplasm or abscess which can induce mechanical airway obstruction
  • Mallampati score 4
  • Obesity (BMI ≥ 35 kg/m2)
  • Obstructive sleep apnea (OSA)
  • Craniofacial anomaly
  • Cormack grade 3b or 4
  • History or high risk of difficult intubation / difficult mask ventilation
  • Patients whom the direct laryngoscopy cannot be used for, because of weak teeth or small mouth opening
  • Patients who refuse to participate in the study or from whom receive informed consent cannot be received.

Trial locations and contacts

1 site in 1 country.

South Korea1 site
  • Seoul National University Bundang Hospital

    Seongnam-si, Gyeonggi-do, 13620

Other trials in South Korea

About this study

Official title: The Effect of Endobronchial Intubation of Double-lumen Tube on Post-operative Sore Throat, Hoarseness and Airway Injuries: A Comparison Between Conventional and Fiberoptic Bronchoscope-guided Intubation

Double lumen tube (DLT) needs to be intubated to isolate ventilations of left and right lungs for thoracic surgery. Post-operative sore throat and hoarseness are more frequent with DLT intubation than with single one. Which is may because DLT is relatively thicker, harder, sideway curved and therefore more likely to damage the vocal cord or trachea during intubation, and advanced deeper to the carina and main bronchus level. In the conventional method of intubation, DLT is rotated 90 degrees and advanced blindly to the main bronchus level after DLT is intubated through vocal cord using the direct laryngoscopy. After the blind advancement, the sufficient tube position needs to be gained and confirmed with the fiberoptic bronchoscope. In the bronchoscope guide method, after DLT is intubated through vocal cord using the direct laryngoscopy, the pathway into the targeted main bronchus is secured using the fiberoptic bronchoscope which is passed through a bronchial lumen of DLT. And then DLT can be advanced through the guide of the bronchoscope. In this study, we intend to compare post-operative sore throat, hoarseness and airway injury between the two methods. We hypothesize that the bronchoscope guide method can reduce the post-operative complications and airway injury because surrounding tissues of the airway can be less irritated by DLT intubation in the guide method than in a conventional.

For a constant guide effect, we use fiberoptic bronchoscopes with same outer diameter (4.1 mm) which can pass through a bronchial lumen of 37 and 39 Fr Lt. DLT and cannot pass through 35 Fr or smaller Lt. DLTs.

Read more

<Lt. DLT size selection>

  • male: ≥160 cm, 39 French; < 160 cm, 37 French
  • female: ≥160 cm, 37 French; < 160 cm, contraindication
Being tested
Bronchoscope guided advancement, Conventional advancement
Medical subject headings
Postoperative Complications, Pharyngitis, Hoarseness, Soft Tissue Injuries

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Bronchoscope guided advancementProcedure or surgery

    During the anesthetic induction for thoracic surgery, Lt. DLT is intubated using the bronchoscope-guided method. The method is as follows.

    1. Lt. DLT is intubated through vocal cord using the direct laryngoscopy.
    2. Pass the fiberoptic bronschoscope through a bronchial lumen of Lt. DLT.
    3. Secure the pathway into the Lt. main bronchus by advancing the bronchoscope into the Lt. main bronchus.
    4. Lt. DLT can be advanced through the guide of the bronchoscope into Lt. main bronchus.
    5. After the advancement, the position of Lt. DLT can be confirmed using the fiberoptic bronchoscope. If necessary, the depth and direction of Lt. DLT should be modified.
  • Conventional advancementProcedure or surgery

    During the anesthetic induction for thoracic surgery, Lt. DLT is intubated using the conventional method. The method is as follows.

    1. Lt. DLT is intubated through vocal cord using the direct laryngoscopy.
    2. Rotate Lt. DLT 90 degrees to the left side.
    3. Advance Lt. DLT blindly to main bronchus level.
    4. After the advancement, the position of Lt. DLT can be confirmed using the fiberoptic bronchoscope. If necessary, the depth and direction of Lt. DLT should be modified.
Study groups in NCT03368599
Study groupRoleWhat they receive
Bronchoscope guide groupExperimentalDLT is advanced into the main bronchus through the guide of fiberoptic bronchoscope (Bronchoscope guided advancement).
Receives: Procedure: Bronchoscope guided advancement
Conventional groupActive comparatorDLT is advanced blindly to the main bronchus level (Conventional advancement).
Receives: Procedure: Conventional advancement

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Post-operative sore throat (24 h)

    The degree of throat pain (Visual Analogue Scale (VAS); 0, no pain; 10, most

    Measured: 24 hour after tracheal extubation

Secondary outcomes (16)
  1. Resistance against DLT passage through vocal cord

    none/mild/severe

    Measured: Intraoperative

  2. Resistance against DLT advancement

    none/mild/severe

    Measured: Intraoperative

  3. Intubation time

    stop of initial mask ventilation - intubation through vocal cord

    Measured: Intraoperative

  4. The number of attempts for intubation

    The number of attempts for intubation through vocal cord

    Measured: Intraoperative

  5. The number of right misplacement of Lt. DLT

    The number of right misplacement of Lt. DLT confirmed using the fiberoptic bronchoscope after the advancement

    Measured: Intraoperative

  6. Time for DLT positioning: stop of initial mask ventilation - success of the 1st fine DLT positioning

    Time for DLT positioning: stop of initial mask ventilation - success of the 1st fine DLT positioning into Lt. main bronchus

    Measured: Intraoperative

  7. Heart rate

    Heart rate Just before Lt. DLT intubation / 2 min after success of the 1st fine DLT positioning

    Measured: Intraoperative

  8. Mean arterial pressure

    Mean arterial pressure Just before Lt. DLT intubation / 2 min after success of the 1st fine DLT positioning

    Measured: Intraoperative

  9. IV PCA

    Fentanyl usage with PCA

    Measured: At 24 hours after the extubation

  10. Airway injury (Lt. main bronhcus, carina, trachea)

    When spontaneous breathing of the patient starts after the thoracic surgery

    Measured: Intraoperative

  11. Airway injury (vocal cord)

    When spontaneous breathing of the patient starts after the thoracic surgery

    Measured: Intraoperative

  12. Post-operative sore throat (1 h)

    The degree of throat pain (Visual Analogue Scale (VAS); 0, no pain; 10, most pain) after tracheal extubation

    Measured: 24 hours after tracheal extubation

  13. Post-operative hoarseness (1 h)

    The incidence of hoarseness after tracheal extubation

    Measured: 1 hour after tracheal extubation

  14. Post-operative hoarseness (24 h)

    The incidence of hoarseness after tracheal extubation

    Measured: 24 hour after tracheal extubation

  15. Oral dryness

    The incidence of oral dryness

    Measured: 24 hours after tracheal extubation

  16. Dysphagia

    The incidence of dysphagia

    Measured: 24 hours after tracheal extubation

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted11 Dec 2017
  2. Study start15 Jan 2018
  3. Primary completion30 Jan 2019
  4. Study completion31 Jan 2019

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
136 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03368599
Sponsor's protocol ID
B-1711-432-005
Status last verified
Sep 2019
First submitted
1 Dec 2017
Last updated
10 Sep 2019
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Christensen AM, Willemoes-Larsen H, Lundby L, Jakobsen KB. Postoperative throat complaints after tracheal intubation. Br J Anaesth. 1994 Dec;73(6):786-7. doi: 10.1093/bja/73.6.786.

    PubMed 7880666
  • McHardy FE, Chung F. Postoperative sore throat: cause, prevention and treatment. Anaesthesia. 1999 May;54(5):444-53. doi: 10.1046/j.1365-2044.1999.00780.x.

    PubMed 10995141
  • Chang JE, Min SW, Kim CS, Han SH, Kwon YS, Hwang JY. Effect of prophylactic benzydamine hydrochloride on postoperative sore throat and hoarseness after tracheal intubation using a double-lumen endobronchial tube: a randomized controlled trial. Can J Anaesth. 2015 Oct;62(10):1097-103. doi: 10.1007/s12630-015-0432-x. Epub 2015 Jul 7.

    PubMed 26149601
  • Park SH, Han SH, Do SH, Kim JW, Rhee KY, Kim JH. Prophylactic dexamethasone decreases the incidence of sore throat and hoarseness after tracheal extubation with a double-lumen endobronchial tube. Anesth Analg. 2008 Dec;107(6):1814-8. doi: 10.1213/ane.0b013e318185d093.

    PubMed 19020122
  • Seo JH, Cho CW, Hong DM, Jeon Y, Bahk JH. The effects of thermal softening of double-lumen endobronchial tubes on postoperative sore throat, hoarseness and vocal cord injuries: a prospective double-blind randomized trial. Br J Anaesth. 2016 Feb;116(2):282-8. doi: 10.1093/bja/aev414.

    PubMed 26787799
  • Cheong KF, Koh KF. Placement of left-sided double-lumen endobronchial tubes: comparison of clinical and fibreoptic-guided placement. Br J Anaesth. 1999 Jun;82(6):920-1. doi: 10.1093/bja/82.6.920.

    PubMed 10562789
  • Knoll H, Ziegeler S, Schreiber JU, Buchinger H, Bialas P, Semyonov K, Graeter T, Mencke T. Airway injuries after one-lung ventilation: a comparison between double-lumen tube and endobronchial blocker: a randomized, prospective, controlled trial. Anesthesiology. 2006 Sep;105(3):471-7. doi: 10.1097/00000542-200609000-00009.

    PubMed 16931978
  • Park JW, Jo JH, Park JH, Bae YK, Park SJ, Cho SW, Han SH, Kim JH. Comparison of conventional and fibreoptic-guided advance of left-sided double-lumen tube during endobronchial intubation: A randomised controlled trial. Eur J Anaesthesiol. 2020 Jun;37(6):466-473. doi: 10.1097/EJA.0000000000001216.

    PubMed 32332265

Questions about this trial

What is this clinical trial studying?

A study testing Bronchoscope guided advancement and Conventional advancement in people with Intubation, Intratracheal and Postoperative Complications, run by Seoul National University Bundang Hospital at 1 site in South Korea.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 15 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 10 Sep 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in South Korea. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Post-operative sore throat (24 h) (time frame: 24 hour after tracheal extubation). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03368599, which also lists 8 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Sep 2019.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in